ASCO GI: Biologic Helps in Esophageal Cancer (CME/CE)

SAN FRANCISCO (MedPage Today) — Three-fourths of patients with advanced esophageal cancer had major responses when cetuximab (Erbitux) was added to chemoradiation, investigators reported here.

Post a Comment

Comments are closed.